Source author record

Anthony Szedlak

Anthony Szedlak appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
1topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2015arXiv

Evolutionary and topological properties of gene modules and driver mutations in a leukemia gene regulatory network

The diverse, specialized genes in today's lifeforms evolved from a common core of ancient, elementary genes. However, these genes did not evolve individually: gene expression is controlled by a complex network of interactions, and alterations in one gene may drive reciprocal changes in its proteins' binding partners. We show that the topology of a leukemia gene regulatory network is strongly coupled with evolutionary properties. Slowly-evolving ("cold"), old genes tend to interact with each other, as do rapidly-evolving ("hot"), young genes, causing genes to evolve in clusters. We argue that gene duplication placed old, cold genes at the center of the network, and young, hot genes on the periphery, and demonstrate this with single-node centrality measures and two new measures of efficiency. Integrating centrality measures with evolutionary information, we define a medically-relevant "cancer network core," strongly enriched for common cancer mutations ($p=2\times 10^{-14}$). This could aid in identifying driver mutations and therapeutic targets.

preprint2014arXiv

Control of asymmetric Hopfield networks and application to cancer attractors

The asymmetric Hopfield model is used to simulate signaling dynamics in gene/transcription factor networks. The model allows for a direct mapping of a gene expression pattern into attractor states. We analyze different control strategies aiming at disrupting attractor patterns using selective local fields representing therapeutic interventions. The control strategies are based on the identification of signaling $bottlenecks$, which are single nodes or strongly connected clusters of nodes that have a large impact on the signaling. We provide a theorem with bounds on the minimum number of nodes that guarantee controllability of bottlenecks consisting of strongly connected components. The control strategies are applied to the identification of sets of proteins that, when inhibited, selectively disrupt the signaling of cancer cells while preserving the signaling of normal cells. We use an experimentally validated non-specific network and a specific B cell interactome reconstructed from gene expression data to model cancer signaling in lung and B cells, respectively. This model could help in the rational design of novel robust therapeutic interventions based on our increasing knowledge of complex gene signaling networks.